ACETAMINOPHEN, ASPIRIN; CAFFEINE-2 | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Clinical Trials
- Clinical Trials
Drugs in Dev.
News
Blog
Market Place
Login

ACETAMINOPHEN, ASPIRIN; CAFFEINE-2
Canada

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Contact Supplier

TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Contact Supplier

pharmacompass-2-m-2026-04-20

ACETAMINOPHEN, ASPIRIN; CAFFEINE-2

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 10 USDMF, 10 CEP/COS, 11 JDMF, 1 EU WC, 8 KDMF, 18 NDC API, 33 Listed Suppliers

69 API Suppliers
10 USDMF
10 CEP/COS
11 JDMF
1 EU WC
8 KDMF
18 NDC API
33 Listed Suppliers

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

FINISHED DOSAGE FORMULATIONS

548 FDF Dossiers, 126 FDA Orange Book, 160 Europe, 38 Canada, 131 South Africa, 93 Listed Dossiers

548 FDF Dossiers
126 FDA Orange Book
160 Europe
38 Canada
131 South Africa
93 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 100MG;1MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUPPOSITORY;RECTAL - 100MG;2MG, TABLET;ORAL - 325MG;50MG;40MG

CAPSULE;ORAL - 356.4MG;30MG;16MG
TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 325MG;50MG;40MG;30MG
TABLET;ORAL - 250MG;250MG;65MG
TABLET;ORAL - 100MG;1MG
TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SUPPOSITORY;RECTAL - 100MG;2MG
TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 2 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 ICE Pharma, 18 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 13 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 18 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 21 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 46 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 4 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 3 Finar, 15 Gangwal Chemicals, 3 Gloria Interchem, 1 Hayashibara, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 2 JJ Chemicals, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 26 Microlex e.U, 1 Nanjing Bold Chemical, 5 Neelkanth MineChem, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 46 Roquette, 20 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

106 Fillers, Diluents & Binders, 66 Thickeners and Stabilizers, 66 Coating Systems & Additives, 58 Topical, 58 Solubilizers, 49 Direct Compression, 48 Disintegrants & Superdisintegrants, 45 Parenteral, 44 Taste Masking, 42 Granulation, 35 Controlled & Modified Release, 32 Film Formers & Plasticizers, 28 Lubricants & Glidants, 27 Emulsifying Agents, 26 Chewable & Orodispersible Aids, 21 Surfactant & Foaming Agents, 20 API Stability Enhancers, 19 Co-Processed Excipients, 10 Rheology Modifiers, 9 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

106 Fillers, Diluents & Binders
66 Thickeners and Stabilizers
66 Coating Systems & Additives
58 Topical
58 Solubilizers
49 Direct Compression
48 Disintegrants & Superdisintegrants
45 Parenteral
44 Taste Masking
42 Granulation
35 Controlled & Modified Release
32 Film Formers & Plasticizers
28 Lubricants & Glidants
27 Emulsifying Agents
26 Chewable & Orodispersible Aids
21 Surfactant & Foaming Agents
20 API Stability Enhancers
19 Co-Processed Excipients
10 Rheology Modifiers
9 Empty Capsules
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

38 News #PharmaBuzz

38 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 5 Regulatory FDF Prices

38 US Medicaid Prescriptions
5 Regulatory FDF Prices

MARKET PLACE

95 APIs, 4 FDF Dossiers

95 APIs
4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 15 Others

2 EDQM
2 JP
15 Others

ANALYTICAL

1 BioAnalytical Methods, 13 Analytical Methods

1 BioAnalytical Methods
13 Analytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

38 All

01 1BAYER INC

02 6APOTEX INC

03 6ARALEZ PHARMACEUTICALS CANADA INC

04 2KENVUE CANADA INC.

05 3LABORATOIRE RIVA INC.

06 7Pharmascience Inc.

07 12TEVA CANADA LIMITED

08 1VITA HEALTH PRODUCTS INC

filter Active Ingredients Reset all filters

38 All

01 11BUTALBITAL

02 20CAFFEINE

03 7Caffeine

filter Dosage Form Reset all filters

38 All

01 18CAPSULE

02 20TABLET

filter Brand Name Reset all filters

38 All

01 1A.C.& C TABLETS

02 1AC&C TABLETS

03 1ACETAMINOPHEN 500 MG COMPOUND TABLETS WITH CODEINE

04 1ACETAMINOPHEN WITH CODEINE - CAPLET

05 1ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE

06 2ACETAMINOPHEN, CAFFEINE & CODEINE

07 1ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS

08 2APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE

09 2APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2

10 2APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4

11 1C-2 BUFFERED WITH CODEINE

12 1EXTRA STRENGTH TYLENOL DAYTIME RELIEF

13 2FIORINAL

14 2FIORINAL-C 1/2

15 2FIORINAL-C 1/4

16 1MIDOL COMPLETE

17 1TEVA-LENOLTEC NO. 1

18 1TEVA-LENOLTEC NO. 2

19 1TEVA-LENOLTEC NO. 3

20 4TEVA-TECNAL

21 2TEVA-TECNAL C 1/2

22 2TEVA-TECNAL C 1/4

23 2TRIANAL TABLET

24 1TYLENOL ULTRA RELIEF

25 1ULTRA HEADACHE RELIEF

List of Suppliers

Product Main Page

01

BAYER INC

PEGS Boston Summit

Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

Brand Name : MIDOL COMPLETE

Dosage Form : TABLET

Dosage Strength : 60MG

Packaging : 16/32

Approval Date :

Application Number : 2275201

Regulatory Info : NON-PRESCRIPTION DRUGS

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2554615

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2554615

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2554623

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2554623

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 2554690

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

APOTEX INC

PEGS Boston Summit

Not Confirmed

APOTEX INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Brand Name : APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging :

Approval Date :

Application Number : 2554690

Regulatory Info : CONTROLLED DRUGS (CDSA IV)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 40MG

Packaging : 100

Approval Date :

Application Number : 176192

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/4

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 176192

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

ARALEZ PHARMACEUTICALS CANADA INC

PEGS Boston Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Brand Name : FIORINAL-C 1/2

Dosage Form : CAPSULE

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number : 176206

Regulatory Info : NARCOTICS (CDSA I)

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.